Login

HealthBeacon CEO James Joyce discusses the company's €25m fundraising and going public on Euronext's growth market in Dublin with Proactive. 00:10:00

Share On Facebook Share On Twitter

The chief executive of HealthBeacon, Jim Joyce

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exploring AQ Magnit's Impact: Unveiling Bulgaria's Sustainable Energy Advancements | Claes Mellgren - Chairman of AQ Group AB
00:10:00
Start Your Financial Modeling Journey with FMI Foundations
00:10:00
Navigating the Intersection of Private Equity and Macroeconomics | Rashad Rahman , Managing Director , Bruckmann, Rosser, Sherrill & Co.
00:10:00
Ole Kristian Jødahl, CEO of Alimak Group (ALIG), features in VD-interviews on Investor Relations.|OLE KRISTIAN JØDAHL is PRESIDENT AND CEO Alimak Group
00:10:00
Electric utility in the Cayman Islands outlines growth trajectory and renewable energy initiatives, underscoring stability and attractive investor returns | Richard Hew, CEO,Caribbean Utilities Company Ltd.
00:10:00
Exploring Political Philosophy with Mark Blitz: Insights from Harvard and Beyond|Mark Blitz,Professor,Claremont McKenna College
00:10:00
Joining the ESG Data Convergence Initiative: Insights and Impact
00:10:00
Fatima Aliko-Dangote's Consumer Rights Address 2024 | Arvind Pathak - Managing Director of Dangote Cement Plc
00:10:00
Embracing the Long Game: Nuveen's Commitment to Financial Stability and Innovation | Jose Minaya , CEO ,  Nuveen Investments.
00:10:00
Hartford CEO Christopher J. Swifton Economic Outlook, Inflation, and California's Regulatory Challenges | Christopher J. Swift, CEO , The Hartford.
00:10:00
Atlas Energy to build a 42 mile conveyor belt | John Turner, CEO, Atlas Energy Solutions IncAESI:NYQ
00:10:00
EY Chairman Carmine Di Sibio Discusses Hiring Trends, AI Impact, and European Market Strength | Carmine Di Sibio, Chairman, Ernst & Young.

© 2017 - Neuhu+